• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, November 1, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Blood arsenic species linked to higher odds of pregnancy hypertension in Chinese cohort

by
October 29, 2026
in Health
Reading Time: 3 mins read
0
Blood arsenic species linked to higher odds of pregnancy hypertension in Chinese cohort

Blood arsenic species linked to higher odds of pregnancy hypertension in Chinese cohort

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A prospective birth cohort study in eastern Yunnan, China, has found that pregnant women with higher concentrations of arsenic in the As(V) form in whole blood had modestly higher odds of developing hypertensive disorders of pregnancy.

Women who went on to develop hypertensive disorders of pregnancy had higher whole-blood As(V) concentrations than those who did not, with geometric means of 2.10 versus 1.34 ng/mL and mean values of 3.96 versus 3.07 ng/mL, a difference that reached statistical significance. Each doubling of As(V) concentration was associated with a 24 percent increase in the odds of these disorders, with an adjusted odds ratio of 1.24 and a 95 percent confidence interval of 1.03 to 1.49. Women in the highest tertile of As(V) exposure had roughly three times the odds of the outcome compared with those in the lowest tertile, with an odds ratio of 3.04 and a confidence interval of 1.39 to 6.62, and the trend across tertiles was statistically significant. Restricted cubic spline analysis suggested an overall association, but found no significant evidence that the relationship departed from linearity.

The authors themselves urge caution about these findings. In their conclusion, they note that the association with As(V) was observed under limit-of-detection substitution approaches, but was not statistically significant in a detected-only analysis, which yielded an odds ratio of 1.17 with a confidence interval of 0.78 to 1.75 and a p-value of 0.462. They also state that residual confounding related to maternal body mass index cannot be excluded, and that the clinical relevance of the association requires cautious interpretation. The study was conducted in a setting of low-level environmental arsenic exposure, a context in which evidence on arsenic species during pregnancy has remained limited.

Beyond the blood-pressure findings, the study examined birth weight using Bayesian kernel machine regression to explore the joint associations of the arsenic species mixture. These analyses suggested species-specific and mixture-related associations with birth weight, with monomethylarsonic acid, known as MMA, showing relatively greater importance within the arsenic mixture. The researchers also applied unsupervised clustering to characterize arsenic metabolic patterns among the participants, and this exploratory analysis identified arsenic-speciation profiles that differed mainly in MMA concentrations and in methylation indices. The authors suggest that heterogeneity in arsenic methylation, particularly involving MMA and methylation indices, may contribute to differences in individual susceptibility.

The study team, led by Yang Xu, Tiantian Zhao and Heng Bai with senior author Huixin Wu, emphasizes that arsenic speciation and metabolism deserve attention when evaluating maternal and fetal health effects of arsenic exposure. The authors conclude that their findings warrant confirmation in larger prospective studies before any clinical implications can be drawn. As a prospective cohort of 437 women in one region of China, the study captures associations rather than proven causal effects, and its results on birth weight are described as exploratory. The work was published as an open-access article on 29 October 2026.

Subject of Research: Associations of maternal whole-blood arsenic species with hypertensive disorders of pregnancy and birth weight in a prospective birth cohort

Article Title: Association of whole-blood arsenic speciation with hypertensive disorders of pregnancy and birth weight: a prospective birth cohort study

Article References: Xu, Y., Zhao, T., Bai, H., Liu, L., Yan, T., Liu, H., Ma, Q. Y., You, D., Li, H., Bai, H., & Wu, H. (2026). Association of whole-blood arsenic speciation with hypertensive disorders of pregnancy and birth weight: a prospective birth cohort study. BMC Pregnancy and Childbirth. https://doi.org/10.1186/s12884-026-10146-9

Image Credits: AI Generated

DOI: 10.1186/s12884-026-10146-9

Keywords: arsenic, hypertensive disorders of pregnancy, birth weight, birth cohort, arsenic speciation, methylation, MMA, environmental exposure, pregnancy, epidemiology, Association, whole-blood

News Source: Harold Sullivan. (October 29, 2026). Blood arsenic species linked to higher odds of pregnancy hypertension in Chinese cohort. Scienmag.

Tags: arsenicarsenic speciationAssociationbirth cohortbirth weightenvironmental exposureEpidemiologyHypertensive disorders of pregnancymethylationMMAPregnancywhole blood
Share12Tweet7Share2ShareShareShare1

Related Posts

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

October 30, 2026
Most Ethiopian HIV patients on dolutegravir therapy show good knowledge, survey finds

Most Ethiopian HIV patients on dolutegravir therapy show good knowledge, survey finds

October 30, 2026

Serum and urine protein biomarkers may sharpen prostate cancer detection beyond PSA

October 30, 2026

One gene locus flags atrial fibrillation risk after major surgery, UK Biobank study finds

October 30, 2026

POPULAR NEWS

  • Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

    Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

    29 shares
    Share 12 Tweet 7
  • Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast

    29 shares
    Share 12 Tweet 7
  • ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

    29 shares
    Share 12 Tweet 7
  • Systematic review maps sustainability tensions in offshore wind development

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 86 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.